Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Oct 17;322(5900):449-52.
doi: 10.1126/science.1161550.

Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele

Affiliations

Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele

E Stice et al. Science. .

Abstract

The dorsal striatum plays a role in consummatory food reward, and striatal dopamine receptors are reduced in obese individuals, relative to lean individuals, which suggests that the striatum and dopaminergic signaling in the striatum may contribute to the development of obesity. Thus, we tested whether striatal activation in response to food intake is related to current and future increases in body mass and whether these relations are moderated by the presence of the A1 allele of the TaqIA restriction fragment length polymorphism, which is associated with dopamine D2 receptor (DRD2) gene binding in the striatum and compromised striatal dopamine signaling. Cross-sectional and prospective data from two functional magnetic resonance imaging studies support these hypotheses, which implies that individuals may overeat to compensate for a hypofunctioning dorsal striatum, particularly those with genetic polymorphisms thought to attenuate dopamine signaling in this region.

PubMed Disclaimer

Figures

Fig 1
Fig 1
A. Coronal section of weaker activation in the left caudate nucleus (−15, 18, 12, T = 3.65, p <0.05 FDR corrected) in response to milkshake receipt versus tasteless solution receipt as a function of BMI with the graph of parameter estimates from that region (Study 1). B. Coronal section of weaker activation in the left caudate nucleus (−12, 3, 27, T = 4.00, p <0.05 FDR corrected) in response to milkshake receipt versus tasteless solution receipt as a function of BMI with the graph of parameter estimates from that region (Study 2).
Fig 2
Fig 2
Coronal section of weaker activation bilaterally in the putamen (−30, 0, 6, T = 3.98, p <0.05 FDR corrected; 27, 3, 9, T = 3.45, p <0.05 FDR corrected) in response to milkshake receipt versus tasteless solution receipt as a function of BMI with the graph of parameter estimates from that region (Study 2).
Fig 3
Fig 3
A. Sagittal section of weaker activation in the left caudate nucleus (−12, −3, 24, T = 4.00, p <0.05 FDR corrected; −9, 0, 15. T = 4.00, p <0.05 FDR corrected) during milkshake receipt versus tasteless solution receipt as a function of BMI depending upon A1 allele status. The graph shows the parameter estimates of the contrast (milkshake receipt versus tasteless solution receipt) across BMI scores for each DRD2 allele type (Study 1). B. Coronal section of weaker activation in the left caudate nucleus (−9, 0, 24, T = 3.81, p <0.05 FDR corrected) during milkshake receipt versus tasteless solution receipt across BMI scores for each DRD2 allele type, with the graph showing the parameter estimates of the contrast (milkshake receipt versus tasteless solution receipt) versus BMI for each allele type (Study 2).
Fig 4
Fig 4
A. Activation in the caudate nucleus was negatively related to future weight gain for participants with the A1 allele, but positively related to future weight gain for participants without the A1 allele (Study 1). B. Activation in the putamen was negatively related to future weight gain for participants with the A1 allele, but positively related to future weight gain for participants without the A1 allele (Study 2).

Comment in

References

    1. Comings DE, Blum K. Prog Brain Res. 2000;126:325. - PubMed
    1. Small DM, Jones-Gotman M, Dagher A. Neuroimage. 2003;19:1709. - PubMed
    1. Szczypka M, et al. Neuron. 2001;30:819. - PubMed
    1. Small DM, Zatorre RJ, Dagher A, Evans AC, Jones-Gotman M. Brain. 2001;124:1720. - PubMed
    1. Pagnoni G, Zink CF, Montague PR, Berns GS. Nature Neuroscience. 2002;5:97. - PubMed

MeSH terms

Substances